We're excited to have you on board

Good Morning,

I would like to share with you MarketBeat’s list of 13 stocks that large institutional investors have been devouring shares of in the last 90 days.

Hedge funds, university endowments, pension funds, and sovereign wealth funds have been pouring money into these companies.

Institutional investors don’t get easily swayed by the hot stocks of the day that are popular with retail investors. They are disciplined. They don’t take dumb losses.

When institutions start to pour money into a company, it’s because they have done extensive analysis and believe a company is undervalued compared to the broader market.

On this list, you will find real companies that are backed by real earnings and real fundamentals.

These stocks have solid future growth prospects. If they didn’t, institutional investors wouldn’t be writing them a check.

You might ask, where did this proprietary list of companies even come from?

No, we didn’t steal it from a trading desk at a major bank.

Our team combed through more than 5,000 SEC 13D and 13F filings issued with the SEC in the last quarter to see where institutional money is flowing.

The 13 stocks on this list stick out like a sore thumb – big money investors are pouring hundreds of millions of dollars into these companies.

You are going to want to see this list of companies before making your next trade.

See the 13 Stocks Institutional Investors Won't Stop Buying Here

MarketBeat Staff
MarketBeat

---

Today's Bonus Offer

"Singularity" stock set for 12,400% gain (Ad)

In my hands is a report for a "Singularity" stock that I believe could grow 12,400% by 2030. Because there's a major event coming as soon as 3 months from today… That's according to one of the world's top AI scientists. Someone who provides AI research to employees at Google, Microsoft, Tesla, Lockheed Martin, IBM, and Amazon. You won't believe what's about to happen next – and how it could push this stock to grow 12,400%.

Click here for the full demonstration

---

Understanding 13F Filings: A Brief Overview

13F filings are quarterly reports that institutional investment managers with discretionary authority over $100 million or more in assets are required to file with the U.S. Securities and Exchange Commission (SEC). Named after the form used for this report, the "Form 13F," these filings aim to provide transparency into the holdings of major institutional investors. Here's what you need to know about 13F filings:

1. What's Disclosed:

   • The 13F filing lists all of the institutional investor's equity holdings that are traded on U.S. exchanges, including stocks, ETFs, and some types of options and convertible bonds. However, it does not include non-equity assets like bonds or commodities.

2. Frequency and Timing:

   • These filings occur quarterly and must be submitted within 45 days of the end of each quarter. This means that the data can be somewhat dated by the time it becomes publicly available.

3. Public Availability:

   • 13F filings are publicly accessible through the SEC's EDGAR database. This transparency allows individual investors, analysts, and other market participants to see what major institutional investors are buying, holding, or selling.

4. Limitations:

   • While the 13F provides valuable insights, it has limitations such as not disclosing short positions or overseas holdings. The data is also somewhat dated, and there is no way to know if the institutional investor has changed positions in the time between the end of the quarter and the filing deadline.

For investors, 13F filings can offer a wealth of information, including the opportunity to follow the investment moves of renowned fund managers like Warren Buffett. However, it's important to understand the limitations of this data and to use it as just one tool among many when making investment decisions.

 

 
This message is a paid advertisement sent on behalf of a third-party advertiser of MarketBeat. Why did I receive this email?
 
If you have questions about your subscription, feel free to contact our U.S. based support team via email at contact@marketbeat.com or leave us a voicemail at (844) 978-6257.
 
If you would no longer like to receive promotional emails from MarketBeat advertisers, you can unsubscribe or manage your mailing preferences here.
 
© 2006-2023 American Consumer News, LLC dba MarketBeat.
326 E 8th St #105, Sioux Falls, SD 57103. United States.

 

Today's Bonus Content: How A.I. Could Make Most 21st Century Diseases EXTINCT